BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27245191)

  • 1. G-CSF Dosing to Prevent Recurrent Clozapine-Induced Agranulocytosis.
    Freeman GM; Martin BA; Hu RJ
    Am J Psychiatry; 2016 Jun; 173(6):643. PubMed ID: 27245191
    [No Abstract]   [Full Text] [Related]  

  • 2. Add-on filgrastim during clozapine rechallenge unsuccessful in preventing agranulocytosis.
    Hazewinkel AW; Bogers JP; Giltay EJ
    Gen Hosp Psychiatry; 2013; 35(5):576.e11-2. PubMed ID: 23395419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Agranulocytosis caused by clozapine: the importance of leukocyte monitoring and efficacy of hematopoietic growth factors].
    van Melick EJ; Touw DJ; Haak HL
    Ned Tijdschr Geneeskd; 1995 Nov; 139(47):2437-40. PubMed ID: 8524426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of filgrastim to prevent severe clozapine-induced agranulocytosis.
    Majczenko TG; Stewart JT
    South Med J; 2008 Jun; 101(6):639-40. PubMed ID: 18475227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful Use of Single Doses of Granulocyte-Colony Stimulating Factor (G-CSF) in the Treatment of Late-Onset Agranulocytosis Associated With Clozapine in a Patient With Treatment-Resistant Schizophrenia: A Case Report.
    Comacchio C; Dusi N; Lasalvia A
    J Clin Psychopharmacol; 2016 Apr; 36(2):173-4. PubMed ID: 26859277
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Cytokines and agranulocytosis induced by clozapine.
    Malek-Ahmadi P
    Can J Psychiatry; 1996 Nov; 41(9):603. PubMed ID: 8946085
    [No Abstract]   [Full Text] [Related]  

  • 7. Treating chemotherapy induced agranulocytosis with granulocyte colony-stimulating factors in a patient on clozapine.
    Kolli V; Denton K; Borra D; Pulluri M; Sharma A
    Psychooncology; 2013 Jul; 22(7):1674-5. PubMed ID: 23059755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine-induced agranulocytosis: a case report. Immunopathophysiological considerations.
    van de Loosdrecht AA; Faber HJ; Hordijk P; Uges DR; Smit A
    Neth J Med; 1998 Jan; 52(1):26-9. PubMed ID: 9573739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Add-on filgrastim during clozapine rechallenge in patients with a history of clozapine-related granulocytopenia/agranulocytosis.
    Joffe G; Eskelinen S; Sailas E
    Am J Psychiatry; 2009 Feb; 166(2):236. PubMed ID: 19188296
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic dilemmas in treatment-resistant bipolar patients.
    Bota RG; Sagduyu K
    South Med J; 2008 Jun; 101(6):584. PubMed ID: 18475231
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of cytokines in clozapine-induced agranulocytosis.
    Chin-Yee I; Bezchlibnyk-Butler K; Wong L
    Can J Psychiatry; 1996 Jun; 41(5):280-4. PubMed ID: 8793147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between clozapine-induced agranulocytosis and HLA subtyping.
    Lopez-Garcia P; Teresa Rodriguez J; De Castro P; Landecho I; Zapata R
    J Clin Psychiatry; 2006 Oct; 67(10):1652-3. PubMed ID: 17107265
    [No Abstract]   [Full Text] [Related]  

  • 13. G-CSF and the management of clozapine-induced agranulocytosis.
    Gerson SL
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():139-42. PubMed ID: 7525542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
    Hägg S; Rosenius S; Spigset O
    Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of agranulocytosis secondary to rechallenge with clozapine following severe neutropenia during previous therapy.
    Lertxundi U; Sanchez P; Hernandez R; Elizagarate E
    J Clin Psychiatry; 2011 Dec; 72(12):1659. PubMed ID: 22244024
    [No Abstract]   [Full Text] [Related]  

  • 16. Clozapine-Associated Agranulocytosis Treatment With Granulocyte Colony-Stimulating Factor/Granulocyte-Macrophage Colony-Stimulating Factor: A Systematic Review.
    Lally J; Malik S; Whiskey E; Taylor DM; Gaughran FP; Krivoy A; Flanagan RJ; Mijovic A; MacCabe JH
    J Clin Psychopharmacol; 2017 Aug; 37(4):441-446. PubMed ID: 28437295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of clozapine-induced granulocytopenia/agranulocytosis with granulocyte-colony stimulating factor (G-CSF) in an intellectually disabled patient with schizophrenia.
    Rajagopal G; Graham JG; Haut FF
    J Intellect Disabil Res; 2007 Jan; 51(Pt 1):82-5. PubMed ID: 17181606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopharmacology. Clozapine and agranulocytosis.
    Feldman J
    Psychiatr Serv; 1996 Nov; 47(11):1177-8. PubMed ID: 8916231
    [No Abstract]   [Full Text] [Related]  

  • 19. G-CSF plasma levels in clozapine-induced neutropenia.
    Jauss M; Pantel J; Werle E; Schröder J
    Biol Psychiatry; 2000 Dec; 48(11):1113-5. PubMed ID: 11094146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of clozapine-associated agranulocytosis with granulocyte colony-stimulating factor (G-CSF).
    Chengappa KN; Gopalani A; Haught MK; McChesney K; Baker RW; Schooler NR
    Psychopharmacol Bull; 1996; 32(1):111-21. PubMed ID: 8927660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.